Diabetic Foot Ulcer Prevention Strategies: A Proactive Approach to Limb Preservation

Diabetic foot ulcers (DFUs) are among the most serious and costly complications of diabetes mellitus, affecting an estimated 15–25% of people with diabetes during their lifetime (Armstrong, Boulton, & Bus, 2017). They represent a leading cause of hospitalization, lower-limb amputation, reduced quality of life, and substantial healthcare expenditure worldwide. The pathophysiology of DFU development is multifactorial, typically involving the interplay of peripheral neuropathy, peripheral artery disease (PAD), and biomechanical foot deformities. However, research consistently demonstrates that the majority of these devastating ulcers are preventable through consistent, evidence-based preventive strategies that combine patient education, regular professional foot care, glycemic management, and appropriate wound care interventions (Bus et al., 2016). This article details essential measures for preventing DFUs, emphasizing patient education, daily foot care, professional examinations, and the emerging role of hypochlorous acid (HOCl) solutions in maintaining foot skin integrity and preventing infection.

Understanding the Diabetic Foot at Risk

Diabetes mellitus induces several physiological changes that progressively compromise foot health and increase susceptibility to ulceration. Understanding these mechanisms is essential for implementing effective prevention strategies.

• Diabetic Neuropathy: This is the most significant risk factor for DFU development. Chronic hyperglycemia damages peripheral sensory, motor, and autonomic nerves, leading to loss of protective sensation (particularly touch and temperature perception), intrinsic foot muscle weakness with resulting deformities, and dry, cracked skin due to reduced sweating (Pop-Busui et al., 2017). Patients with neuropathy may not perceive minor injuries, blisters, or pressure from ill-fitting footwear, allowing these insults to progress unnoticed into full-thickness ulcers.
• Peripheral Artery Disease (PAD): Atherosclerosis narrows arteries and reduces blood flow to the lower extremities. This impairs tissue oxygenation, slows wound healing, and increases susceptibility to infection. Symptoms can include claudication (leg pain with activity), non-healing wounds, and cold extremities. The coexistence of PAD and neuropathy significantly amplifies ulcer risk.
• Foot Deformities: Motor neuropathy causes intrinsic foot muscle imbalance, leading to structural deformities such as Charcot neuroarthropathy, hammer toes, bunions, and prominent metatarsal heads. These deformities create abnormal pressure concentrations during ambulation, substantially increasing the risk of skin breakdown and ulceration (Rogers et al., 2011).
• Hyperglycemia: Chronically elevated blood glucose levels impair neutrophil function, reduce collagen synthesis, hinder angiogenesis, and compromise the overall wound healing cascade. The Diabetes Control and Complications Trial (DCCT) Research Group (1993) established that intensive glycemic control reduces the risk of neuropathy by up to 60% in type 1 diabetes.

The Foundation of Prevention: Patient Education and Self-Care

Empowering patients with knowledge and practical self-care skills is the cornerstone of DFU prevention. Structured patient education programs have been shown to reduce ulcer incidence significantly (Bus et al., 2016).

1. Daily Foot Inspection

• How: Patients should inspect their feet daily, looking for any cuts, cracks, blisters, redness, swelling, warmth, or nail problems. A hand-held mirror or assistance from a family member can facilitate inspection of the soles and heels. Any abnormality, no matter how minor, should prompt immediate self-care or professional consultation.
• Why: Early detection of minor injuries or skin changes allows for prompt intervention before they escalate into ulcers. Given that neuropathy eliminates the protective pain response, visual inspection becomes the primary early warning system.

2. Proper Foot Hygiene

• Washing: Wash feet daily with lukewarm water (below 37°C) and mild soap. Patients should test water temperature with a thermometer or elbow before immersing feet to avoid burns, which is especially critical for those with sensory neuropathy.
• Drying: Thoroughly dry feet, paying special attention to the interdigital spaces, to prevent fungal infections such as tinea pedis, which can cause maceration and skin breakdown that serves as a portal for bacterial entry.
• Moisturizing: Apply a general-purpose moisturizing lotion to dry skin on the feet, avoiding application between the toes to prevent maceration. Xerosis (excessively dry skin) predisposes to fissuring, which can become entry points for infection.

3. Nail Care

• Trimming: Trim toenails straight across, filing any sharp edges with an emery board. If direct nail trimming is difficult due to poor vision, neuropathy, or onychomycosis, patients should seek professional podiatry care. Avoid cutting nails too short or rounding the corners, which can lead to ingrown toenails (onychocryptosis) and subsequent infection.

4. Footwear and Socks

• Appropriate Shoes: Wear shoes that fit properly, are well-cushioned, and provide adequate support with a wide toe box. Shoes should be inspected daily for any foreign objects (e.g., pebbles, sharp seams) before putting them on. Patients should never go barefoot, even indoors, to prevent accidental injury.
• Socks: Wear clean, dry socks daily. Seamless socks or those specifically designed for people with diabetes (non-binding tops, moisture-wicking fabric, antimicrobial properties) are recommended. Avoid socks with tight elastic bands that can constrict circulation and create pressure marks.

5. Activity and Circulation

• Regular Movement: Encourage patients to perform ankle dorsiflexion, plantarflexion, and rotation exercises periodically, especially during prolonged sitting or lying down, to promote venous return and arterial circulation to the feet.
• Avoid Prolonged Pressure: Crossing legs or ankles for extended periods can impede circulation and create pressure points. Patients should change positions regularly and avoid prolonged immobility.

Professional Foot Care and Regular Examinations

In addition to daily self-care, regular professional evaluation is vital for early identification of risk factors and timely intervention. The International Working Group on the Diabetic Foot (IWGDF) recommends risk-stratified screening intervals based on individual patient risk profiles (Bus et al., 2016).

1. Annual Comprehensive Foot Exam by a Healthcare Provider

• What it includes: This exam should be performed annually (or more frequently for high-risk individuals) by a physician, podiatrist, or trained diabetes educator. It involves:
  • History: Assessing past foot problems, ulcer history, amputation history, current symptoms, and self-care practices.
  • Inspection: Examining the skin for calluses, fissures, signs of infection, and overall foot structure.
  • Neurological Assessment: Using a 10-g Semmes-Weinstein monofilament to test for protective sensation at designated plantar sites and assessing vibratory perception and reflexes (Pop-Busui et al., 2017).
  • Vascular Assessment: Checking dorsalis pedis and posterior tibial pulses, assessing skin temperature, color, and capillary refill time. Ankle-brachial index (ABI) may be performed when PAD is suspected.
  • Musculoskeletal Assessment: Identifying any deformities (e.g., Charcot foot, prominent metatarsal heads, hammer toes) or areas of abnormal pressure.
  • Footwear Assessment: Evaluating the fit, condition, and appropriateness of the patient’s shoes and socks.

2. Podiatry Referral

• When: Patients with existing foot deformities, confirmed neuropathy, PAD, a history of ulcers or amputations, or those who cannot perform adequate self-care should be referred to a podiatrist regularly (e.g., every 1–3 months for high-risk patients). Regular professional callus debridement reduces plantar pressure and ulcer risk (Armstrong et al., 2017).

Managing Specific Risk Factors

• Glycemic Control: Strict management of blood glucose levels is paramount for DFU prevention. The DCCT Research Group (1993) demonstrated that intensive glycemic therapy reduced the development of clinical neuropathy by 64% over 5 years in type 1 diabetes. Similarly, the UK Prospective Diabetes Study (UKPDS, 1998) confirmed significant microvascular risk reduction with improved glycemic control in type 2 diabetes. Current guidelines recommend individualized HbA1c targets, generally below 7% for most adults, to reduce complication risk.
• Smoking Cessation: Smoking critically impairs microcirculation and oxygen delivery, exacerbating PAD and impairing tissue repair. Smoking cessation is essential for maintaining vascular health and reducing DFU risk. Healthcare providers should offer structured cessation support.
• Management of Calluses and Hyperkeratosis: Plantar calluses develop at sites of repetitive high pressure and are strong predictors of subsequent ulceration. Regular professional debridement of calluses reduces peak plantar pressure and has been associated with reduced ulcer recurrence (Armstrong et al., 2017).
• Hygiene in Wound Management and the Role of HOCl: For existing minor skin breakdown, pre-ulcerative lesions, or established ulcers, proper wound care is essential to prevent infection and progression. Hypochlorous acid (HOCl) has emerged as a highly effective antimicrobial and wound-cleansing agent. HOCl is a naturally produced molecule by neutrophils during the oxidative burst, providing broad-spectrum antimicrobial activity against bacteria, viruses, and fungi while being non-cytotoxic to human cells at therapeutic concentrations (Sakarya et al., 2014). Clinical studies have demonstrated that HOCl solutions effectively reduce bacterial bioburden in chronic wounds, including diabetic foot ulcers, without impairing granulation tissue formation or re-epithelialization. The use of HOCl for routine foot cleansing in high-risk patients may help maintain skin microbiome balance and prevent the infections that can transform minor skin breaks into serious ulcers. HOCl wound care solutions offer a safe, non-toxic option for daily foot hygiene in diabetic patients at risk for DFUs.

Footwear Technology and Offloading

Specialized footwear and orthotics play a critical role in redistributing pressure away from high-risk areas and preventing mechanical skin breakdown.

• Therapeutic Footwear: Prescribed therapeutic shoes are designed to accommodate foot deformities, provide cushioning, reduce shear forces, and prevent friction. For patients with a history of ulceration, therapeutic footwear has been shown to significantly reduce ulcer recurrence (Bus et al., 2016).
• Custom Orthotics: Custom-molded insoles and inserts can correct biomechanical abnormalities, redistribute plantar pressure forces away from high-risk zones, and accommodate deformities to reduce focal pressure concentrations.
• Total Contact Casting (TCC): For active neuropathic plantar ulcers, TCC remains the gold standard for offloading pressure and promoting healing by distributing weight evenly across the entire plantar surface and lower leg, effectively eliminating focal pressure at the ulcer site (Rogers et al., 2011).
• General Footwear Advice: Patients should be educated to shop for shoes late in the day when feet are largest, ensure adequate toe box depth and width, choose breathable materials, and break in new shoes gradually. Skin treatment products appropriate for diabetic skin should be used to maintain skin integrity and prevent fissuring.

The Role of HOCl in DFU Prevention: An Evidence-Based Perspective

Hypochlorous acid (HOCl) represents an important advancement in preventive foot care for diabetic patients. As a naturally occurring antimicrobial agent produced by the innate immune system, HOCl provides rapid, broad-spectrum antimicrobial activity with an excellent safety profile. Research by Sakarya et al. (2014) demonstrated that HOCl solution significantly reduced bacterial colonization in chronic wounds, including diabetic foot infections, without cytotoxicity to fibroblasts or keratinocytes at concentrations used clinically.

For DFU prevention specifically, HOCl offers several advantages: (1) it can be used for daily foot cleansing to reduce microbial load on at-risk skin; (2) it effectively treats tinea pedis and bacterial colonization that can lead to skin breakdown; (3) it is non-irritating and does not cause the tissue damage associated with harsh antiseptics such as povidone-iodine or hydrogen peroxide; and (4) it does not contribute to antimicrobial resistance, making it suitable for long-term daily use in high-risk populations. Incorporating HOCl into a comprehensive foot care regimen—alongside daily inspection, moisturizing, appropriate footwear, and professional surveillance—provides an additional layer of protection against the infections that often trigger DFU development in compromised diabetic skin.

Conclusion

Preventing diabetic foot ulcers is a critical, achievable goal that requires a multifaceted, proactive approach grounded in evidence-based practice. It begins with robust patient education on daily self-care, emphasizing meticulous foot inspection, proper hygiene, appropriate footwear, and circulation-promoting activities. This must be complemented by regular, comprehensive professional foot examinations following IWGDF risk-stratified guidelines and prompt management of identified risk factors, including poor glycemic control, PAD, and pre-ulcerative skin changes. The integration of HOCl-based wound care solutions into daily foot hygiene regimens offers an additional, evidence-supported strategy for reducing microbial burden and preventing the infections that precipitate ulceration. By combining these strategies, healthcare providers and patients can work collaboratively to preserve limb integrity and significantly reduce the incidence of DFUs and subsequent amputations. Explore our advanced **wound-care** resources for more information on HOCl-based solutions for diabetic foot health.

Frequently Asked Questions (FAQ)

Q1: What are the main risk factors for developing diabetic foot ulcers?

A1: The primary risk factors are diabetic peripheral neuropathy (loss of protective sensation and foot deformities), peripheral artery disease (PAD) reducing tissue perfusion, foot deformities creating abnormal pressure points, and prolonged hyperglycemia that impairs immune function and wound healing (Pop-Busui et al., 2017).

Q2: How often should I check my feet if I have diabetes?

A2: You should inspect your feet daily for any cuts, blisters, redness, swelling, warmth, nail changes, or skin abnormalities. Use a mirror or ask for help to see the soles of your feet.

Q3: What is the most important thing I can do to prevent foot problems?

A3: Daily self-care—including thorough foot inspection, proper hygiene, wearing properly fitting shoes and socks, and maintaining good blood glucose control—is paramount. Regular professional foot examinations are equally important (Bus et al., 2016).

Q4: Should I see a doctor for minor cuts or blisters on my feet?

A4: Yes, any injury to the foot, no matter how small, should be evaluated promptly by a healthcare professional, especially if you have diabetes. Minor skin breaks can rapidly progress to serious infections and ulcers in the presence of neuropathy and hyperglycemia.

Q5: How do ill-fitting shoes contribute to diabetic foot ulcers?

A5: Ill-fitting shoes cause repetitive friction, shear forces, and pressure concentrations, particularly on areas of the foot affected by neuropathy or deformities. Because neuropathy eliminates pain perception, these injuries go unnoticed and can become infected, leading to ulceration (Armstrong et al., 2017).

Q6: Is wound irrigation important for diabetic foot ulcers?

A6: Yes, wound irrigation is crucial for cleansing diabetic foot ulcers, removing debris and biofilm, and reducing bacterial bioburden. Solutions such as sterile saline and HOCl are recommended for their efficacy, safety, and non-cytotoxic properties that support the healing environment (Sakarya et al., 2014).

Q7: Can HOCl help prevent diabetic foot ulcers?

A7: HOCl can be a valuable component of a DFU prevention strategy. Its broad-spectrum antimicrobial activity, non-cytotoxicity, and safety for daily use make it suitable for routine foot cleansing in high-risk diabetic patients, helping to reduce microbial load and prevent infections that can lead to skin breakdown and ulceration.

References

Armstrong, D. G., Boulton, A. J. M., & Bus, S. A. (2017). Diabetic foot ulcers and their recurrence. New England Journal of Medicine, 376(24), 2367–2375. https://doi.org/10.1056/NEJMra1615439

Bus, S. A., van Netten, J. J., Lavery, L. A., Monteiro-Soares, M., Rasmussen, A., Jubiz, Y., & Price, P. E. (2016). IWGDF Guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diabetes/Metabolism Research and Reviews, 32(S1), 16–24. https://doi.org/10.1002/dmrr.2696

Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329(14), 977–986. https://doi.org/10.1056/NEJM199309303291401

Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017). Diabetic neuropathy: A position statement by the American Diabetes Association. Diabetes Care, 40(1), 136–154. https://doi.org/10.2337/dc16-2042

Rogers, L. C., Frykberg, R. G., Armstrong, D. G., Boulton, A. J. M., Edmonds, M., Van, G. H., Hartemann, A., Game, F., Jeffcoate, W., Jirkovska, A., Jude, E., Morbach, S., Morrison, W. B., Pinzur, M., Pitocco, D., Sanders, L., Wukich, D. K., & Uccioli, L. (2011). The Charcot foot in diabetes. Diabetes Care, 34(9), 2123–2129. https://doi.org/10.2337/dc11-0844

Sakarya, S., Gunay, N., Karakulak, M., Ozturk, B., & Ertugrul, B. (2014). Hypochlorous acid: An ideal wound care agent with powerful microbicidal, antibiofilm, and wound healing potency. Wounds, 26(12), 342–350. PMID: 25785777

UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet, 352(9131), 837–853. https://doi.org/10.1016/S0140-6736(98)07019-6